Literature DB >> 4330007

Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormone. An approach to distinguishing hypothalamic from pituitary forms of idiopathic hypopituitary dwarfism.

B H Costom, M M Grumbach, S L Kaplan.   

Abstract

To test the hypothesis that the primary defect in some patients with idiopathic hypopituitary dwarfism is failure to secrete hypothalamic hypophysiotropic-releasing factors, synthetic thyrotropin-releasing factor (TRF), 500 mug, wa given intravenously, and timed venous samples obtained for determination of the concentration of plasma TSH by radioimmunoassay in three groups of subjects: (a) 11 patients without evidence of endocrine or systemic disease, (group I) (b) 8 with isolated growth hormone deficiency and normal thyroid function, (group II) and (c) 9 patients with idiopathic hypopituitary dwarfism and thyroid-stimulating hormone (TSH) deficiency (group III). The mean fasting plasma TSH value was 4.1 muU/ml in group I, and 3.9 muU/ml in group II; in both groups there was a brisk rise in plasma TSH to peak levels of 12-45 muU/ml at 30-45 min, and a fall toward base line levels at 120 min. All children in group III had basal TSH levels of < 1.5 muU/ml; one failed to respond to TRF; eight exhibited a rise in plasma TSH with peak values comparable with those in groups I and II. In four of eight children in group III who responded to TRF, the TSH response was delayed and the initial rise in plasma TSH was not detectable until 10-60 min. In these four patients, plasma TSH levels continued to rise at 120 min. The mean fasting concentration of plasma thyroxine iodide (T(4)) in subjects with normal thyroid function (groups I and II) was 5.6 mug/100 ml, and the mean plasma T(4) level at 120 min was 6.6 mug/100 ml. This difference between fasting and postTRF plasma T(4) was significant (P < 0.001) by paired analysis. Mean fasting plasma T(4) concentration in group III patients was 1.3 mug/100 ml; after TRF a significant rise in T(4) concentration was not detected in this group. The results indicate that TRF test is useful in distinguishing between primary hypothalamic and pituitary forms of TSH deficiency. In light of the evidence of TRF deficiency in eight of nine patients with idiopathic hypopituitary dwarfism, it seems likely that in these patients, other pituitary hormone deficiencies may be attributable to deficiency of their respective releasing factors.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4330007      PMCID: PMC292157          DOI: 10.1172/JCI106717

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Growth and growth hormone. II. A comparison of isolated growth-hormone deficiency and multiple pituitary-hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism.

Authors:  H G Goodman; M M Grumbach; S L Kaplan
Journal:  N Engl J Med       Date:  1968-01-11       Impact factor: 91.245

Review 2.  Hypothalamic pituitary stimulating and inhibiting hormones.

Authors:  S M McCann; J C Porter
Journal:  Physiol Rev       Date:  1969-04       Impact factor: 37.312

Review 3.  Neuroendocrine aspects of mammalian reproduction.

Authors:  J W Everett
Journal:  Annu Rev Physiol       Date:  1969       Impact factor: 19.318

4.  Isolation and properties of porcine thyrotropin-releasing hormone.

Authors:  A V Schally; T W Redding; C Y Bowers; J F Barrett
Journal:  J Biol Chem       Date:  1969-08-10       Impact factor: 5.157

5.  Isolation of growth hormone-releasing hormone(GRH) from porcine hypothalami.

Authors:  A V Schally; S Sawano; A Arimura; J F Barrett; I Wakabayashi; C Y Bowers
Journal:  Endocrinology       Date:  1969-06       Impact factor: 4.736

6.  Growth and growth hormone. IV. Limitations of the growth hormone response to insulin and arginine and of the immunoreactive insulin response to arginine in the assessment of growth hormone deficiency in children.

Authors:  R Youlton; S L Kaplan; M M Grumbach
Journal:  Pediatrics       Date:  1969-06       Impact factor: 7.124

7.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa.

Authors:  J Landon; F C Greenwood; T C Stamp; V Wynn
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

8.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects.

Authors:  F C Greenwood; J Landon; T C Stamp
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

9.  Simplified, partially automated method for radioimmunoassay of human thyroid-stimulating, growth, luteinizing, and follicle stimulating hormones.

Authors:  W D Odell; P L Rayford; G T Ross
Journal:  J Lab Clin Med       Date:  1967-12

10.  Growth hormone-releasing factor (GRF): physiological and biochemical studies with GRF preparations of bovine and porcine origin.

Authors:  A V Schally; E E Muller; A Arimura; T Saito; S Sawano; C Y Bowers; S L Steelman
Journal:  Ann N Y Acad Sci       Date:  1968-02-05       Impact factor: 5.691

View more
  22 in total

1.  Hypothalamic hormones.

Authors:  S S Yen
Journal:  Calif Med       Date:  1973-07

2.  Thyrotrophin-releasing Hormone.

Authors: 
Journal:  Br Med J       Date:  1973-01-13

3.  Traumatic hypopituitarism due to a gunshot wound.

Authors:  D Trujillo-Juarez; F L Culler; R S Ganelin; K L Jones
Journal:  West J Med       Date:  1987-11

4.  Hypothalamic-hypothyroidism secondary to Sheehan's syndrome.

Authors:  P A Singer; J H Mestman; P R Manning; J T Nicoloff
Journal:  West J Med       Date:  1974-05

5.  Synthesized releasing hormones.

Authors:  B M Sheikholislam
Journal:  Calif Med       Date:  1972-08

6.  Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.

Authors:  P J Snyder; R D Utiger
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

7.  Thyrotrophin estimation in diagnosis and treatment of childhood thyroid disorders.

Authors:  D Jackson; M Vanderschueren-Lodeweyckx; D B Grant
Journal:  Arch Dis Child       Date:  1975-07       Impact factor: 3.791

8.  Hypothalamic hypothyroidism due to isolated thyrotropin-releasing hormone (TRH) deficiency.

Authors:  H Katakami; Y Kato; M Inada; H Imura
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

9.  [Familial panhypopituitarism].

Authors:  D Hamann; T Olbricht; B P Hauffa; D Reinwein
Journal:  Klin Wochenschr       Date:  1991-10-02

10.  Survival and growth in a woman with untreated hypothalamic panhypopituitarism of 21 years' duration.

Authors:  G Tolis; S Cruess; M Goldstein; H G Friesen; J G Rochefort
Journal:  Can Med Assoc J       Date:  1974-09-21       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.